Epidemiology of Canine Keratoconjunctivitis Sicca and the Efficacy of Cyclosporine and Tacrolimus in its Clinical Management and Tear Production: A Comparative Study
DOI:
https://doi.org/10.48165/ijvsbt.22.1.14Keywords:
Canine, Cyclosporine, Keratoconjunctivitis sicca, Schirmer tear test, Tacrolimus, Tear productionAbstract
Keratoconjunctivitis sicca (KCS) or dry eye is a significant cause of ocular morbidity in dogs. This study was aimed to determine the incidence of KCS and to compare the therapeutic efficacy of oil-based 2% cyclosporine and 0.03% tacrolimus ointment. Over a period of one-year, KCS was the most frequently diagnosed ophthalmic condition (24.70%, 41/166) among canine ocular affections. Incidence of KCS was the highest in dogs aged 1-5 years (65.85%), in females (58.54%), and in the Pug breed (43.90%). For the therapeutic trial, 26 client-owned dogs (52 eyes) were divided into two treatment groups: cyclosporine and tacrolimus and monitored for 60 days. The key clinical parameters, viz., ocular discharge, conjunctival hyperaemia, corneal pigmentation and Schirmer tear test (STT) values were systematically scored. Both treatments significantly mitigated the inflammatory signs of ocular discharge and conjunctival hyperaemia (p<0.05). Treatment with tacrolimus successfully arrested the advancement of pigmentation, particularly in mild KCS cases, showing a statistically significant (p<0.05) advantage over 2% cyclosporine. 0.03% tacrolimus was also found to be significantly superior (p<0.05) to 2% cyclosporine in increasing STT values across all severity groups (mild, moderate, and severe) by day 60. In severe KCS cases, only tacrolimus produced a statistically significant increase in tear production. These findings underscores that while both agents address superficial inflammation, tacrolimus has a superior lacrimostimulant effect providing a superior therapeutic outcome by controlling the vision-threatening progression of corneal pigmentation for the management of canine KCS.
Downloads
References
Balicki, I., Radziejewski, K., & Silmanowicz, P. (2008). Studies on keratoconjunctivitis sicca incidence in crossbred dogs. Polish Journal of Veterinary Sciences, 11(4), 353–358.
Berdoulay, A., English, R. V., & Nadelstein, B. (2005). Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. Veterinary Ophthalmology, 8(4), 225–232.
Best, L. J., Hendrix, D. V., & Ward, D. A. (2014). Diagnosis & treatment of keratoconjunctivitis sicca in dogs. Today’s Veterinary Practice, 4, 16–22.
Bhavsar, A. S., Bhavsar, S. G., & Jain, S. M. (2011). A review on recent advances in dry eye: Pathogenesis and management. Oman Journal of Ophthalmology, 4(2), 50–56.
Bounous, D. I., Carmichael, K. P., Kaswan, R. L., Hirsh, S., & Stiles, J. (1995). Effects of ophthalmic cyclosporine on lacrimal gland pathology and function in dogs with keratoconjunctivitis sicca. Veterinary and Comparative Ophthalmology, 5(1), 5–12.
Corr, A. (2015). Canine keratoconjunctivitis sicca (KCS): Canine dry eye. Metropolitan Veterinary Associates & Emergency Services Newsletter, 4(1), 2.
Dana, M. R., & Hamrah, P. (2002). Role of immunity and inflammation in corneal and ocular surface disease associated with dry eye. In Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3: Basic Science and Clinical Relevance (pp. 729–738).
Dodi, P. L., Zanotti, C., Rossi, S., & Aloe, L. (2009). Tear level of nerve growth factor in normal dogs. Acta Ophthalmologica, 87, 327.
Dodi, P. L. (2015). Immune-mediated keratoconjunctivitis sicca in dogs: Current perspectives on management. Veterinary Medicine, 6, 341–347.
Giuliano, E. A., & Moore, C. P. (2007). Diseases and surgery of the lacrimal secretory system. In Veterinary Ophthalmology (4th ed., pp. 633–661).
Hendrix, D. V., Adkins, E. A., Ward, D. A., Stuffle, J., & Skorobohach, B. (2011). An investigation comparing the efficacy of topical ocular application of tacrolimus and cyclosporine in dogs. Veterinary Medicine International, 2011, 487592.
Izci, C., Celik, I., Alkan, F., Ogurtan, Z., Ceylan, C., Sur, E., & Ozkan, Y. (2002). Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca. American Journal of Veterinary Research, 63(5), 688–694.
John, C. (2017). Early detection, pathophysiology and management of keratoconjunctivitis sicca in canine (M.V.Sc. Thesis). Indian Veterinary Research Institute, Izatnagar, Bareilly, UP, India.
Kaswan, R. L., Martin, C. L., & Chapman, W. L., Jr. (1984). Keratoconjunctivitis sicca: Histopathologic study of nictitating membrane and lacrimal glands from 28 dogs. American Journal of Veterinary Research, 45(1), 112–118.
Kino, T., Hatanaka, H., Miyata, S., Inamura, N., Nishiyama, M., Yajima, T., Goto, T., Okuhara, M., Kohsaka, M., & Aoki, H. (1987). FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. The Journal of Antibiotics, 40(9), 1256–1265.
Matheis, F. L., Walser-Reinhardt, L., & Spiess, B. M. (2012). Canine neurogenic keratoconjunctivitis sicca: 11 cases (2006–2010). Veterinary Ophthalmology, 15(4), 288–290.
Radziejewski, K., & Balicki, I. (2016). Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca. Acta Veterinaria Hungarica, 64(3), 313–329.
Renwick, P. (1996). Diagnosis and treatment of corneal disorders in dogs. In Practice, 18(7), 315–328.
Slatter, D. H. (2001). Basic diagnostic tests. In D. H. Slatter (Ed.), Fundamentals of Veterinary Ophthalmology (3rd ed., pp. 85–123). Saunders, Saint Louis, Missouri, USA.
Snedecor, G. W., & Cochran, W. G. (2014). Statistical Methods (8th ed.). Iowa State University Press, Ames, Iowa, USA.
Strubble, D. T. (1991). Ophthalmic examination and diagnostic procedures. In K. N. Gelatt (Ed.), Veterinary Ophthalmology (3rd ed., pp. 427–430). Lippincott Williams & Wilkins, Baltimore, Maryland, USA.
Thomson, A. W., Bonham, C. A., & Zeevi, A. (1995). Mode of action of tacrolimus (FK506): Molecular and cellular mechanisms. Therapeutic Drug Monitoring, 17(6), 584–591.
Williams, D. L. (2005). Analysis of tear uptake by the Schirmer tear test strip in the canine eye. Veterinary Ophthalmology, 8(5), 325–330.
Williams, D. L. (2008). Immunopathogenesis of keratoconjunctivitis sicca in the dog. Veterinary Clinics of North America: Small Animal Practice, 38(2), 251–268.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Indian Journal of Veterinary Sciences and Biotechnology

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

